Skip to main content
S 1410 108th Congress Senate Health Access to health care Advertising Agriculture and Food Alternative medicine Commerce Communication in medicine Deceptive advertising Dietary supplements Drug approvals Drug industry Drug interactions Drugs Evidence (Law) Food industry Government Operations and Politics Government paperwork Health warnings Informed consent (Medical law) Labeling

Access to Medical Treatment Act

Introduced: July 15, 2003 See on congress.gov
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 15, 2003
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 15, 2003
Sponsor introductory remarks on measure. (CR S9422-9423)
Jul 15, 2003
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Access to Medical Treatment Act - Permits any individual to be treated by a health care practitioner with any medical treatment that the individual desires (including a treatment that is not approved, certified, or licensed by the Secretary of Health and Human Services) if: (1) the practitioner agrees to treat the individual; and (2) the administration of such treatment does not violate licensing laws.

Declares that health care practitioners may/shall (sic) provide any method of treatment to such an individual if certain requirements are met.

Requires a practitioner to report: (1) administering such treatment and discovering it to be a danger to an individual; and (2) the positive effects of an unconventional medical treatment for a life-threatening medical condition.

States that nothing in this Act shall in any way adversely affect the distribution or sale of dietary supplements.

What's happening now July 15, 2003

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1410: Access to Medical Treatment Act. 108th Congress. Open America. https://openamerica.io/bill/108-S-1410/
MLA
"S. 1410: Access to Medical Treatment Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-1410/.
Bluebook (legal)
S. 1410, 108th Cong. (2026), https://openamerica.io/bill/108-S-1410/.
Markdown link
[S. 1410: Access to Medical Treatment Act](https://openamerica.io/bill/108-S-1410/)
Report a problem